Mary T. Szela
CEO and President, Director · TriSalus Life Sciences, Inc.
- 2025
- Oct 7, 2026
- 11
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Mary T. Szela files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Michael P. Stansky - $3.01M in TLSI purchases and sales in the last 12 months
- Mats Wahlstrom - $152K in TLSI purchases and sales in the last 12 months
- William Valle - $125K in TLSI purchases and sales in the last 12 months
- Gary B. Gordon - $65K in TLSI purchases and sales in the last 12 months
- David Patience - $32K in TLSI purchases and sales in the last 12 months
- Richard Marshak - $17K in TLSI purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Mary T. Szela?
Mary T. Szela is a corporate insider, tracked as CEO and President, Director of TriSalus Life Sciences, Inc. (TLSI). InsiderAlpha holds 11 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Mary T. Szela submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Mary T. Szela been buying or selling stock?
Recorded transactions: 3 open-market purchases ($377K) and 2 open-market sales ($79K) across all tracked filings.
